Research from Water Tower Research, Water Tower Research

Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Research from Water Tower Research

Equity Research Firm

Equity Bottom-Up

<ul><li>A cell-free biomanufacturing platform advances toward commercial validation.</li><li>eXoZymes has spent nearly a decade developing engineered enzymes and cell-free production systems designed to manufacture molecules that can be difficult or uneconomic to source through conventional methods.</li><li>Its asset-light approach retains ownership of the underlying process IP, enzymes, methods, and know-how, while outsourcing manufacturing to external partners. </li></ul>

A cell-free biomanufacturing platform advances toward commercial validation.eXoZymes has spent nearly a decade developing engineered enzymes and cell-free production systems designed to manufacture molecules that can be difficult or uneconomic to source through conventional methods.Its asset-light approach retains ownership of the underlying process IP, enzymes, methods, and know-how, while outsourcing manufacturing to external partners. 

EXOZ: Converting Cell-Free Science into a Scalable and Repeatable Commercial Opportunity